Health CommitteeWritten Evidence: Contents
Here you can browse the Written Evidence ordered by the House of Commons to be printed 3 July 2014.
- Written evidence from Arthritis Care (LTC 02)
- Written evidence from the British Acupuncture Council (LTC 03)
- Written evidence from The Royal College of Radiologists (LTC 04)
- Written evidence from Together for Short Lives (LTC 05)
- Written evidence from the British Heart Foundation (LTC 06)
- Written evidence from the Chartered Society of Physiotherapy (LTC 08)
- Written evidence from Nichola Ebbern (LTC 09)
- Written evidence from the Lymphoedema Support Network (LTC 10)
- Written evidence from Prostate Cancer UK (LTC 12)
- Written evidence from the ME Association (LTC 13)
- Written evidence from Celesio UK and Lloydspharmacy (LTC 14)
- Written evidence from the Pemphigus Vulgaris Network (LTC 15)
- Written evidence from Action Duchenne (LTC 16)
- Written evidence from Centre for Mental Health (LTC 17)
- Written evidence from YoungMinds (LTC 18)
- Written evidence from The College of Optometrists (LTC 19)
- Written evidence from reMEmber (The Chronic Fatigue Society) (LTC 20)
- Written evidence from The Nottingham Traumatic Brain Injury Service (LTC 21)
- Written evidence from Dwayne Johnson (LTC 22)
- Written evidence from the Joint Epilepsy Council (LTC 23)
- Written evidence from MSD-UK Ltd (LTC 24)
- Written evidence from the MND Association (LTC 25)
- Written evidence from the Association of Directors of Adult Social Services and the Local Government Association (LTC 26)
- Written evidence from the Urology User Group Coalition (LTC 27)
- Written evidence from Mrs Christine Talbot (LTC 28)
- Written evidence from Doreen (LTC 29)
- Written evidence from the Care Quality Commission (LTC 30)
- Written evidence from Genzyme Therapeutics Ltd (LTC 31)
- Written evidence from the UK Centre for Tobacco Control Studies (LTC 32)
- Written evidence from British Lymphology Society (LTC 33)
- Written evidence from Sanofi Diabetes (LTC 34)
- Written evidence from the Association of British Clinical Diabetologists (LTC 35)
- Written evidence from Crohn’s and Colitis UK (LTC 36)
- Written evidence from Scope (LTC 37)
- Written evidence from Julie Hinks (LTC 38)
- Written evidence from the Royal National Institute of Blind People (LTC 39)
- Written evidence from Action for M.E. (LTC 40)
- Written evidence from Baxter Healthcare (LTC 41)
- Written evidence from the British Association for Counselling and Psychotherapy (LTC 42)
- Written evidence from the Society of Chiropodists and Podiatrists (LTC 44)
- Written evidence from the National Ankylosing Spondylitis Society (NASS) (LTC 45)
- Written evidence from the British Association and College of Occupational Therapists (LTC 46)
- Written evidence from the Royal College of Physicians of Edinburgh (LTC 47)
- Written evidence from Sue Ryder (LTC 48)
- Written evidence from Vertex Pharmaceuticals UK (LTC 50)
- Written evidence from Astellas Pharma Ltd (LTC 51)
- Written evidence from Macmillan Cancer Support (LTC 52)
- Written evidence from Alliance Boots (LTC 53)
- Written evidence from Novo Nordisk (LTC 54)
- Written evidence from the National Housing Federation (LTC 55)
- Written evidence from Epilepsy Action (LTC 57)
- Written evidence from Parkinson’s UK (LTC 58)
- Written evidence from the British Specialist Nutrition Association (LTC 59)
- Written evidence from Terrence Higgins Trust (LTC 60)
- Written evidence from the Urology Trade Association (LTC 61)
- Written evidence from the Multiple Sclerosis Trust (LTC 62)
- Written evidence from the Optical Confederation (LTC 63)
- Written evidence from Coloplast (LTC 64)
- Written evidence from The Society of Homeopaths (LTC 65)
- Written evidence from The Work Foundation (LTC 68)
- Written evidence from Napp Pharmaceutical Group (LTC 70)
- Written evidence from the British Pain Society and the RCGP Clinical Champion for Chronic Pain (LTC 71)
- Written evidence from the AntiCoagulation Self-Monitoring Alliance (LTC 72)
- Written evidence submitted on behalf of Roche Diagnostics UK (LTC 73)
- Written evidence from Janssen (LTC 74)
- Written evidence from the national Dose Adjustment For Normal Eating programme (LTC 75)
- Written evidence from the British Dermatological Nursing Group (LTC 76)
- Written evidence from the Association of the British Pharmaceutical Industry (LTC 77)
- Written evidence from the Health Foundation (LTC 78)
- Written evidence from Stroke Association (LTC 79)
- Written evidence from Men’s Health Expert Policy Group (LTC 80)
- Written evidence from Action on Hearing Loss (LTC 83)
- Written evidence from the British Society for Allergy & Clinical Immunology (LTC 85)
- Written evidence from The Association of British Neurologists (LTC 86)
- Written evidence from Gilead Sciences (LTC 87)
- Written evidence from the British Society for Rheumatology (LTC 88)
- Written evidence from the British Association of Dermatologists (LTC 89)
- Written evidence from Accenture (LTC 90)
- Written evidence from the Association of Young People with ME (LTC 92)
- Written evidence from NHS Confederation (LTC 94)
- Written evidence from Bosch Healthcare UK (LTC 95)
- Written evidence from the ME Trust (LTC 97)